Daniel S. Goldman sold Capgemini SE ADR (PINK: CGEMY)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Capgemini SE ADR (CGEMY) since 2023, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Capgemini SE ADR (PINK: CGEMY) on July 10, 2023. Since that trade, CGEMY is down -29.65% against the S&P 500 up +71.78%, an outperformance of -101.43%.
Data updated
Daniel S. Goldman's CGEMY trades vs the price
CGEMY is down -29.65% since Daniel S. Goldman sold on July 10, 2023, versus +71.78% for the S&P 500.
Performance since this trade
All Daniel S. Goldman CGEMY trades
Daniel S. Goldman & CGEMY trading FAQ
Is it legal for Daniel S. Goldman to trade Capgemini SE ADR (CGEMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Capgemini SE ADR (CGEMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell CGEMY?
Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Capgemini SE ADR (CGEMY) on July 10, 2023, according to public STOCK Act filings.
How has CGEMY performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold CGEMY on July 10, 2023, the stock is down -29.65%, versus +71.78% for the S&P 500 over the same period, an outperformance of -101.43%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CGEMY trades?
Quantellect tracks every disclosed congressional trade in Capgemini SE ADR (CGEMY) on the Capgemini SE ADR congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's CGEMY tradesAll congressional filings for Capgemini SE ADRDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.